Terms: = Sarcomas AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
18 results:
1. Germline drivers of gynecologic carcinosarcomas.
Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
[TBL] [Abstract] [Full Text] [Related]
2. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
4. FAT1 and msh2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic treatment.
Zhou C; Sun Y; Gong Z; Li J; Zhao X; Yang Q; Yu H; Ye J; Liang J; Jiang L; Zhang D; Shen Z; Zheng S
J Bone Miner Res; 2022 May; 37(5):885-895. PubMed ID: 35279875
[TBL] [Abstract] [Full Text] [Related]
5. A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma.
Rodwin RL; Janardan SK; Hofstatter EW; Kadan-Lottick NS
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e585-e588. PubMed ID: 35200227
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Laparoscopic Surgery Performed for Lynch Syndrome in a Patient Who Developed Cecal Cancer and Uterine Carcinosarcoma Synchronously].
Murakami T; Matsumoto T; Murashima N; Nishina T; Fujimoto Y; Sugiu K; Nagasaka T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2042-2044. PubMed ID: 30692278
[TBL] [Abstract] [Full Text] [Related]
8. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.
Dogan A; Kern P; Schultheis B; Häusler G; Rezniczek GA; Tempfer CB
BMC Cancer; 2018 Apr; 18(1):463. PubMed ID: 29690864
[TBL] [Abstract] [Full Text] [Related]
9. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
[TBL] [Abstract] [Full Text] [Related]
10. Genital Cancers in Women: Uterine Cancer.
Roett MA
FP Essent; 2015 Nov; 438():11-7. PubMed ID: 26569046
[TBL] [Abstract] [Full Text] [Related]
11. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
[TBL] [Abstract] [Full Text] [Related]
12. A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based treatment.
Hagleitner MM; Coenen MJ; Gelderblom H; Makkinje RR; Vos HI; de Bont ES; van der Graaf WT; Schreuder HW; Flucke U; van Leeuwen FN; Hoogerbrugge PM; Guchelaar HJ; te Loo DM
Clin Cancer Res; 2015 Aug; 21(15):3436-41. PubMed ID: 25829401
[TBL] [Abstract] [Full Text] [Related]
13. Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka S; Greil R; André T; Bennouna J; Sastre J; Van Cutsem E; von Moos R; Osterlund P; Reyes-Rivera I; Müller T; Makrutzki M; Arnold D;
Ann Oncol; 2013 Sep; 24(9):2342-9. PubMed ID: 23852309
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.
Grzankowski KS; Shimizu DM; Kimata C; Black M; Terada KY
Gynecol Oncol; 2012 Sep; 126(3):408-12. PubMed ID: 22617524
[TBL] [Abstract] [Full Text] [Related]
15. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract] [Full Text] [Related]
16. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.
Agarwalla PK; Dunn IF; Turner CD; Ligon KL; Schneider KA; Smith ER
Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094
[TBL] [Abstract] [Full Text] [Related]
17. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome.
Levi Z; Hazazi R; Kedar-Barnes I; Hodak E; Gal E; Mor E; Niv Y; Winkler J
Am J Transplant; 2007 Feb; 7(2):476-9. PubMed ID: 17229076
[TBL] [Abstract] [Full Text] [Related]
18. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models.
Middlemas DS; Stewart CF; Kirstein MN; Poquette C; Friedman HS; Houghton PJ; Brent TP
Clin Cancer Res; 2000 Mar; 6(3):998-1007. PubMed ID: 10741727
[TBL] [Abstract] [Full Text] [Related]
